ADMP Adamis Pharmaceuticals Corporation

1.08
+0.05  (+5%)
Previous Close 1.03
Open 1.04
Price To Book 1.96
Market Cap 66,353,158
Shares 61,438,109
Volume 414,054
Short Ratio
Av. Daily Volume 492,097

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

CRL issued March 27 2015. CRL issued again June 6, 2016. Approval announced June 15, 2017 following third submission.
Epinephrine Pre-filled Syringe (PFS)
Emergency treatment of anaphylaxis.
Phase 3 development on hold - noted May 9, 2019.
APC-1000
Asthma/COPD
FDA Approval announced September 27, 2018.
Symjepi - low dose
Anaphylaxis
PDUFA date October 31, 2019.
Higher Dose Naloxone Injection
Opioid overdose
Refusal to file letter received February 26, 2019.
APC-8000 (sublingual tadalafil)
Erectile dysfunction

Latest News

  1. Adamis Pharmaceuticals Strengthens Patent Portfolio for its U.S. Compounding Subsidiary
  2. Edited Transcript of ADMP earnings conference call or presentation 8-Aug-19 9:00pm GMT
  3. Adamis Pharmaceuticals (ADMP) Reports Q2 Loss, Misses Revenue Estimates
  4. Adamis Pharmaceuticals Announces Second Quarter 2019 Financial Results and Business Update
  5. Did Changing Sentiment Drive Adamis Pharmaceuticals's (NASDAQ:ADMP) Share Price Down A Painful 73%?
  6. Adamis Pharmaceuticals Schedules Second Quarter 2019 Earnings Conference Call and Business Update
  7. Adamis Pharmaceuticals (ADMP) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
  8. Adamis Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Warrants
  9. Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants
  10. Will Flagship Impella Drive ABIOMED's (ABMD) Q1 Earnings?
  11. Masimo (MASI) to Report Q2 Earnings: What's in the Offing?
  12. What's in the Offing for DexCom's (DXCM) Earnings in Q2?
  13. Adamis Pharmaceuticals Provides Update on Litigation with Belcher Pharmaceuticals
  14. Adamis Pharmaceuticals Provides Update on Litigation with kaléo Inc.
  15. Adamis Pharmaceuticals Provides Update on U.S. Retail Launch of SYMJEPI
  16. Novartis launches Adamis allergy shots in U.S. pharmacies amid EpiPen shortage
  17. Have Insiders Been Selling Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Shares?
  18. Adamis Pharmaceuticals Provides Update on Its Higher Dose Naloxone Injection Product
  19. Adamis Pharmaceuticals Announces Patent Litigation Regarding Its Higher Dose Naloxone Injection Product